Skip to main content
RLAY
NASDAQ Life Sciences

Relay 10-Q: $848.6M Cash Into 2029, Q3 Loss $81.7M, ATM Upsized to $463M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$18.02
Mkt Cap
$3.951B
52W Low
$5.95
52W High
$21.27
52W Position info
203% above low
Off High info
15% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

RLAY has more than doubled off its 52-week low of $5.95.

Summary

Relay's Q3 10-Q confirms $848.6M in cash with runway into 2029 against an $81.7M quarterly loss, and details $456.0M raised this year through a May follow-on and ATM sales, with the ATM shelf now upsized to $463.0M.


Key Events · Earnings and Guidance · RLAY

  • Q3 Loss Widens on Higher R&D

    Net loss was $81.7 million, or $0.37 per share, versus $74.1 million ($0.43) a year earlier. R&D rose to $77.1 million from $68.3 million on clinical trial costs plus non-recurring lease termination charges.

  • Cash of $848.6M, Runway Into 2029

    Cash, equivalents and investments totaled $848.6 million at September 30, down from $910.9 million at June 30. Management projects funding into 2029.

  • $456M Raised Via Follow-On and ATM

    Nine-month financing brought in $466.9 million, including $296.8 million net from the May 2026 follow-on of 26,354,167 shares at $12.00 and $159.2 million net from 16,006,569 ATM shares.

  • ATM Shelf Upsized to $463M

    In August 2026 the sales agreement with TD Securities was amended to raise the at-the-market program from $250.0 million to $463.0 million; no shares were sold under it in Q3.


Analysis · RLAY · Life Sciences

The headline numbers were already out via this morning's press release, so the market has seen the $848.6M cash pile and the $81.7M quarterly loss. What the 10-Q adds is the plumbing behind them: $456.0M of equity raised in nine months (a $296.8M May follow-on at $12.00 plus $159.2M of ATM sales), an ATM shelf enlarged to $463.0M in August, and authorized shares lifted to 450 million in June — a company that has been steadily issuing stock to fund a pipeline whose Phase 3 ReDiscover-2 readout is still years out. Cash fell $62.3M in the quarter while R&D rose to $77.1M from $68.3M, so the burn is accelerating even with the runway intact. Also newly detailed: a $1.5M lease termination at One Kendall Square and an October 6 settlement stipulation in the derivative suit over director pay, still awaiting court approval.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RLAY was trading at $18.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4B. The 52-week trading range was $5.95 to $21.27. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RLAY - Latest Insights

RLAY
Nov 04, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $18.02
Real-time Price: $16.17 info
Change: -$1.86 (-10%) info
Market Cap: $3.572B info
RLAY
Sep 22, 2026, 11:23 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $18.54
Real-time Price: $16.17 info
Change: -$2.38 (-13%) info
Market Cap: $3.572B info
RLAY
Aug 25, 2026, 7:43 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $19.88
Real-time Price: $16.17 info
Change: -$3.72 (-19%) info
Market Cap: $3.572B info
RLAY
Aug 06, 2026, 4:41 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $19.30
Real-time Price: $16.17 info
Change: -$3.14 (-16%) info
Market Cap: $3.572B info
RLAY
Aug 06, 2026, 4:40 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $19.04
Real-time Price: $16.17 info
Change: -$2.88 (-15%) info
Market Cap: $3.572B info